Register |

Select an issue:

Monthly Briefing – October 2010 issue

To download the October 2010 briefing and other issues, log in using your Personal Access Code

  • Geraint Roberts reports from ECHA's recent stakeholders' day about the agency's expectations about the first REACH registration deadline, C&L notification and next year's challenges;
  • Our Editor, Mamta Patel, looks at the issues debated at ECHA's workshop in September on the use of non-testing methods for hazard assessment;
  • Sean Milmo examines how scientists on both sides of Atlantic are developing the concept of toxicity testing based on the mapping of toxicological pathways;
  • Mamta Patel explains how a debate about deca-BDE raises the question of how to classify a substance if the parent molecule is not hazardous but it breaks down to congeners that are;
  • In a joint submission, Geraint Roberts and Philippa Jones look at where strategies on endocrine disrupters are heading in the US and EU;
  • With the US mid-term elections looming, Elizabeth Grossman assesses the propsects for TSCA reform if the Republicans make the gains pundits predict;
  • US lawyer Lynn Bergeson sets out industry's concerns about the US EPA's proposed changes to information reporting rules;
  • Emma Chynoweth looks at how US states and companies like Hewlett-Packard are using an NGO-developed tool to move to less hazardous chemicals;
  • Dr REACH, Steffen Erler, explains how a registration number is not necessarily needed straight after the 30 November deadline to prove that a substance is being registered in accordance with REACH;
  • Mayer Brown's Jean-Philippe Montfort and Giovanni Indirli look at companies' duties for substances that need reclassification;
  • In this month's Guest Column, French MP Gérard Bapt argues that governments must do more to reduce the public's exposure to endocrine disrupters.
Cover of CW Briefing October 2010

The monthly PDF briefing is only available to registered subscribers. Follow this link to take a no-obligation 14 day free trial

Registered users: please log in using your Personal Access Code here:

Forgotten your access code? | Take a no-obligation 14 day free trial
-
-


Standard subscription package comprises

Copyright and user licensing:

  • Subscriptions are sold on a "per user" basis, and content may not be shared between users unless appropriate subscription access has been purchased. Please contact us for details.
  • No Chemical Watch content may be copied or recirculated without permission.